Guggenheim Conference on Disruptive Technologies in Immuno-Oncology

March 27, 2018 in New York, New York (USA)

Back to all events

The Guggenheim Conference on Disruptive Technologies in Immuno-Oncology will be held on March 27, 2018 in New York, USA.

André Choulika, Ph.D., Chairman and Chief Executive Officer of Cellectis, to take part in this event from 8:45 AM to 9:30 AM with a presentation entitled "This CAR's Got TALENt".